SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-18-038020
Filing Date
2018-07-12
Accepted
2018-07-11 17:43:18
Documents
5
Effectiveness Date
2018-07-12

Document Format Files

Seq Description Document Type Size
1 S-8 tv498158_s8.htm S-8 65518
2 EXHIBIT 5.1 tv498158_ex5-1.htm EX-5.1 6549
3 EXHIBIT 23.1 tv498158_ex23-1.htm EX-23.1 2197
4 EXHIBIT 23.2 tv498158_ex23-2.htm EX-23.2 3226
5 GRAPHIC image_001.jpg GRAPHIC 3306
  Complete submission text file 0001144204-18-038020.txt   83395
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Filer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-226134 | Film No.: 18949326
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1